Assertio Therapeutics, Inc Intellectual Property Contracts & Agreements

9 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Exclusive License Agreement between Depomed, Inc. and Solvay Pharmaceuticals, Inc. (November 19, 2008)
License Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NY
2009
Settlement and License Agreement between Depomed, Inc. and Teva Pharmaceuticals USA, Inc. (April 4, 2008)
License Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
CA
2008
Sublicense Agreement between PharmaNova Inc. and Depomed, Inc. for Gabapentin Product Development
License Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
CA
2007
Amendment No. 1 to Exclusive License and Marketing Agreement between Depomed, Inc. and Esprit Pharma, Inc.
License Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
2006
Amended and Restated License Agreement between Depomed, Inc. and Biovail Laboratories International SRL for Extended Release Metformin Formulations (Canada)
License Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
2006
Exclusive License and Marketing Agreement between Depomed, Inc. and Esprit Pharma, Inc. (July 21, 2005)
License Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
NJ
2005
Amended Development and License Agreement between DepoMed, Inc. and Biovail Laboratories Incorporated (Extended Release Metformin Formulations)
License Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
2004
Exclusive License Agreement between DepoMed Development, Ltd. and DepoMed, Inc. (September 18, 2003)
License Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
CA
2003
Development and License Agreement (Metformin GR) between DepoMed, Inc. and Biovail Laboratories Incorporated
License Agreements
Assertio Therapeutics, Inc
Pharmaceuticals
2002